NAFLD-related HCC patients with ALBI Grade 3 had worse overall survival when compared to patients with ALBI Grade 1 or 2 (p = 0.00021), and there was no difference in the overall survival between patients with normal or increased baseline serum aminotransferases and among patients stratified by baseline AFP values (cut-off, 10 and 100 μg/L) (Figure 7). This evidence concerns the gene AFP and hepatocellular carcinoma.